APA (7th ed.) Citation

JA, A., L, S., N, F., R, G., R, S., J, L., . . . M, P. (2025). Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment. Frontiers in aging neuroscience, 17, 1681516. https://doi.org/10.3389/fnagi.2025.1681516

Chicago Style (17th ed.) Citation

JA, Allué, et al. "Clinical Validation of a Plasma-based Antibody-free LC-MS Method for Identifying CSF Amyloid Positivity in Mild Cognitive Impairment." Frontiers in Aging Neuroscience 17 (2025): 1681516. https://doi.org/10.3389/fnagi.2025.1681516.

MLA (9th ed.) Citation

JA, Allué, et al. "Clinical Validation of a Plasma-based Antibody-free LC-MS Method for Identifying CSF Amyloid Positivity in Mild Cognitive Impairment." Frontiers in Aging Neuroscience, vol. 17, 2025, p. 1681516, https://doi.org/10.3389/fnagi.2025.1681516.